v3.25.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets    
Cash $ 456,809 $ 155,647
Restricted cash 27,505
Accounts receivable, net of allowances for credit losses of $9,476 and $13,400 6,937 6,966
Accounts receivable – other 48,213
Note receivable 3,500,000
Equity investment 462,500 466,500
Inventories 198,626 212,494
Prepaid expenses and other 505,259 33,830
Deferred offering costs 8,328
Interest receivable 36,888
Total current assets 1,714,177 4,412,325
Computer equipment, net 8,696
Goodwill 98,036,974
Total assets 99,759,847 4,412,325
Current liabilities    
Accounts payable 7,185,781 1,108,777
Accrued compensation 387,167
Accrued creator commissions 2,461,410
Settlement payable 592,901 484,735
Accrued expenses 2,419,743 596,610
Accrued expenses - related parties 309,333 309,333
Accrued sales tax 2,012,462
Deferred revenue 4,273,960 1,919
Convertible notes payable, net of discount 586,296 432,105
Notes payable, current portion, net of discount 4,615,301
Total current liabilities 24,844,354 2,933,479
Total liabilities 24,844,354 2,933,479
Stockholders’ equity    
Series A preferred stock, $0.001 par value – 10,000 shares authorized at March 31, 2025 and December 31, 2024; 9,350 shares issued and outstanding at March 31, 2025 and December 31, 2024, preference in liquidation of $1,653,806 and $1,597,706 at March 31, 2025 and December 31, 2024, respectively 9 9
Series B preferred stock, $0.001 par value – 50,000 shares authorized at March 31, 2025 and December 31, 2024; 50,000 shares issued and outstanding at March 31, 2025 and December 31, 2024, preference in liquidation of $7,500,000 at March 31, 2025 and December 31, 2024 50 50
Series C preferred stock, $0.001 par value – 100,000 and 0 shares authorized at March 31, 2025 and December 31, 2024, respectively; 6,150 and 0 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively; preference in liquidation of $615,000 and $0 at March 31, 2025 and December 31, 20224, respectively 6
Series D preferred stock, $0.001 par value – 750,000 and 0 shares authorized at March 31, 2025 and December 31, 2024, respectively; 750,000 and 0 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively; preference in liquidation of $75,000,000 and $0 at March 31, 2025 and December 31, 20224, respectively 750
Common stock, $0.001 par value - 100,000,000 shares authorized at March 31, 2025 and December 31, 2024; 16,713,398 shares issued and outstanding at March 31, 2025 and December 31, 2024 16,713 16,713
Additional paid-in capital 106,202,074 30,620,875
Accumulated deficit (31,304,109) (29,158,801)
Total stockholders’ equity 74,915,493 1,478,846
Total liabilities and stockholders’ equity $ 99,759,847 $ 4,412,325

Source